ZYKADIA (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the ZYKADIA drug offered from Novartis Pharmaceuticals Corporation. This Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | ceritinib |
| SUBSTANCE NAME: | CERITINIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-04-29 |
| END MARKETING DATE: | 0000-00-00 |
ZYKADIA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZYKADIA from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2014-04-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0640_55dc4f4e-f44d-4314-9b71-4b9d3929314c |
| PRODUCT NDC: | 0078-0640 |
| APPLICATION NUMBER: | NDA205755 |
Other CERITINIB Pharmaceutical Manufacturers / Labelers:
